Skip to Main Content

Author Details

Raymond L Stallings
Royal College of Surgeons in Ireland
1981
157
51
PMIDPaper TitleJournal TitlePublished Year
33918978A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma.Cancers (Basel)2021
33330445A Context-Dependent Role for MiR-124-3p on Cell Phenotype, Viability and Chemosensitivity in Neuroblastoma <i>in vitro</i>.Front Cell Dev Biol2020
30770954Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma.Cell Mol Life Sci2019
29447961A physiologically relevant 3D collagen-based scaffold-neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models.Acta Biomater2018
29900459Endogenous exosome labelling with an amphiphilic NIR-fluorescent probe.Chem Commun (Camb)2018
27826913Assessment of Basic Biological Functions Exerted by miRNAs.Methods Mol Biol2017
28091676Hemispherical platinumâ¿¿:â¿¿silver coreâ¿¿:â¿¿shell nanoparticles for miRNA detection.Analyst2017
28318807MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE.J Autoimmun2017
26824183MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.Oncotarget2016
26646589Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma.Oncotarget2016
26750440Endoplasmic reticulum stress-mediated upregulation of miR-29a enhances sensitivity to neuronal apoptosis.Eur J Neurosci2016
25137037Modulation of chemotherapeutic drug resistance in neuroblastoma SK-N-AS cells by the neural apoptosis inhibitory protein and miR-520f.Int J Cancer2015
26202659Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.Tissue Antigens2015
25960282The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro.Cancer Lett2015
25552301Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy.Brain2015
24391119Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma.Pediatr Blood Cancer2014
25502557CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients.PLoS One2014
25295525Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling.PLoS One2014
25188511MYCN repression of Lifeguard/FAIM2 enhances neuroblastoma aggressiveness.Cell Death Dis2014
24357407Discovery and visualization of miRNA-mRNA functional modules within integrated data using bicluster analysis.Nucleic Acids Res2014
22797059Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs.Oncogene2013
24223803Metastasis suppressor microRNA-335 targets the formin family of actin nucleators.PLoS One2013
23897668Orchestrating osteogenic differentiation of mesenchymal stem cells--identification of placental growth factor as a mechanosensitive gene with a pro-osteogenic role.Stem Cells2013
23835063ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours.Mol Cancer2013
23975788Investigating gene promoter methylation in a mouse model of status epilepticus.Methods Mol Biol2013
23674172Identification of circulating microRNAs in HNF1A-MODY carriers.Diabetologia2013
23448906Subcortical white matter abnormalities because of previously undescribed de-novo 14q12-q13.1 triplication.Clin Dysmorphol2013
23400681MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A.Int J Cancer2013
23531080MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1.Mol Cancer2013
23565812Expressional alterations in functional ultra-conserved non-coding RNAs in response to all-trans retinoic acid--induced differentiation in neuroblastoma cells.BMC Cancer2013
23329364New insights into the genetics of neuroblastoma.Mol Diagn Ther2013
23274701The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.Pediatr Surg Int2013
21796619Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas.Int J Cancer2012
23034519Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.Genome Biol2012
23042116LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.Nat Genet2012
22683779Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects.Nat Med2012
22771761Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death.Exp Neurol2012
22705586Comparative genomic and proteomic analysis of high grade glioma primary cultures and matched tumor in situ.Exp Cell Res2012
22892391MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome.Br J Cancer2012
22662276Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles.PLoS One2012
22615744Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis.PLoS One2012
22305495Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase A oncogene.Mol Cancer2012
22302800Differential DNA methylation patterns define status epilepticus and epileptic tolerance.J Neurosci2012
22382496MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway.Carcinogenesis2012
21860421Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma.Oncogene2012
20669225Genome-wide DNA methylation analysis of neuroblastic tumors reveals clinically relevant epigenetic events and large-scale epigenomic alterations localized to telomeric regions.Int J Cancer2011
22031095miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.Clin Cancer Res2011
22164278miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAs.PLoS One2011
21771658MicroRNA and DNA methylation alterations mediating retinoic acid induced neuroblastoma cell differentiation.Semin Cancer Biol2011
21945804miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132.Am J Pathol2011
  • 1 - 50 of 157

Recommended Authors

Sven Bilke
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 0
Yi-Jue Zhao
The First Affiliated Hospital of Guangxi Medical University
Career Start Year 1998
Number of shared co-authors 0
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 1
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Qing-Rong Chen
Center for Biomedical Informatics and Information Technology
Career Start Year 1996
Number of shared co-authors 2
Li Cai
University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Alexei Protopopov
The University of MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 2
Kristina A Cole
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 3
Doris Steinemann
Hannover Medical School
Career Start Year 1994
Number of shared co-authors 2
Javed Khan
Center for Cancer Research, National Cancer Institute
Career Start Year 1993
Number of shared co-authors 11
Marie-Laure Yaspo
Max Planck Institute for Molecular Genetics
Career Start Year 1992
Number of shared co-authors 1
Julie M Gastier-Foster
Baylor College of Medicine
Career Start Year 1992
Number of shared co-authors 10
Ming-Hui Wei
Yantai Affiliated Hospital of Binzhou Medical University
Career Start Year 1991
Number of shared co-authors 0
Xiao-Ning Chen
College of Geographic and Environmental Science, Northwest Normal University
Career Start Year 1991
Number of shared co-authors 3
Sean M Grimmond
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 2
Abdel G Elkahloun
National Human Genome Research Institute
Career Start Year 1990
Number of shared co-authors 3
Thomas Ried
Center for Cancer Research, National Cancer Institute
Career Start Year 1989
Number of shared co-authors 5
Olivier Delattre
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Career Start Year 1987
Number of shared co-authors 10
Jiannis Ragoussis
McGill University
Career Start Year 1986
Number of shared co-authors 2
Peter Lichter
German Cancer Research Center (DKFZ)
Career Start Year 1986
Number of shared co-authors 4
John D McPherson
Ontario Institute for Cancer Research
Career Start Year 1986
Number of shared co-authors 7
Ann M Killary
The University of Texas M. D. Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 1
Ola Myklebost
Institute for Cancer Research, Oslo University Hospital
Career Start Year 1983
Number of shared co-authors 8
Ching C Lau
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 2
Jeremy A Squire
University of Sao Paulo
Career Start Year 1982
Number of shared co-authors 1
Webster K Cavenee
Ludwig Institute for Cancer Research, University of California San Diego
Career Start Year 1977
Number of shared co-authors 1
Alex Look
Dana-Farber Cancer Institute
Career Start Year 1975
Number of shared co-authors 5
Joe W Gray
Oregon Health and Science University
Career Start Year 1974
Number of shared co-authors 5
Raju Kucherlapati
Harvard Medical School
Career Start Year 1973
Number of shared co-authors 5
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1970
Number of shared co-authors 8

Collaborators

Patrick G Buckley
Beaumont Hospital
Co-authored papers 20
Jo Vandesompele
Co-authored papers 16
Johannes H Schulte
Co-authored papers 12
Angelika Eggert
Co-authored papers 12
Jan Koster
Amsterdam University Medical Centers location AMC
Co-authored papers 8
Pieter Mestdagh
Co-authored papers 7
Jan J Molenaar
Co-authored papers 5
John M Maris
Children's Hospital of Philadelphia
Co-authored papers 4
Gudrun Schleiermacher
Institut Curie
Co-authored papers 3
Norman Delanty
FutureNeuro SFI Research Centre, The Royal College of Surgeons in Ireland
Co-authored papers 3
Cliff Han
Los Alamos National Laboratory
Co-authored papers 2
Michelle Haber
School of Clinical Medicine
Co-authored papers 2
Michael D Hogarty
Co-authored papers 2
Ingrid ÿra
Co-authored papers 2
Peter F Ambros
Children's Cancer Research Institute, Medical University of Vienna
Co-authored papers 2
Aedin C Culhane
Dana-Farber Cancer Institute & Harvard School of Public Health
Co-authored papers 2
Eric N Olson
Co-authored papers 2
Ruth Ladenstein
Children's Cancer Research Institute
Co-authored papers 2
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers 2
Chantal Depondt
Hopital Universitaire de Bruxelles - Hopital Erasme
Co-authored papers 1
David B Goldstein
Institute for Genomic Medicine, Columbia University Irving Medical Center
Co-authored papers 1
Xinwei She
Rosetta Inpharmatics LLC
Co-authored papers 1
Bruno Dallapiccola
Co-authored papers 1
Robert Meller
Co-authored papers 1
Frank Westermann
Co-authored papers 1
Dongliang Ge
Department of Pharmacy, Liyang People's Hospital
Co-authored papers 1
Claudia B Catarino
Friedrich-Baur-Institut, Ludwig-Maximilians-Universitat Munchen
Co-authored papers 1
Zalman Vaksman
Children's Hospital of Philadelphia
Co-authored papers 1
Michael Gill
Co-authored papers 1
Trevor Hawkins
Co-authored papers 1
Release 1.2